The granting of marketing authorisation should therefore be made conditional on the putting in place of a risk management system, owing to the inherent nature of advanced therapy medicinal products. ###>L'Agence peut être sollicitée pour avis, conformément aux dispositions de l'article 57, paragraphe 1, 19/47 PE 374.483v01-00